Status:
COMPLETED
Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05787 (P05712)
Lead Sponsor:
Organon and Co
Conditions:
Pregnancy
Neonates
Eligibility:
FEMALE
18-36 years
Brief Summary
The objective of this trial was to evaluate whether Corifollitropin Alfa treatment for the induction of multifollicular growth in women undergoing controlled ovarian stimulation (COS) prior to in vitr...
Detailed Description
This is a follow-up protocol to prospectively monitor pregnancy, delivery, and neonatal outcome of all women who were treated with Corifollitropin Alfa or recFSH and became pregnant during Base Trial ...
Eligibility Criteria
Inclusion
- Participants who received at least one dose of either Corifollitropin Alfa or
- Puregon®/Follistim® AQ Cartridge in Base Trial P05787 (NCT00696800);
- Ongoing pregnancy confirmed by ultrasound at least 10 weeks after embryo transfer in Base Trial P05787 (NCT00696800);
- Able and willing to give written informed consent.
Exclusion
- None
Key Trial Info
Start Date :
July 13 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 15 2009
Estimated Enrollment :
541 Patients enrolled
Trial Details
Trial ID
NCT00703014
Start Date
July 13 2006
End Date
March 15 2009
Last Update
September 19 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.